| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/2001 | EP1076705A2 Transcription and gene expression regulators |
| 02/21/2001 | EP1076704A1 Il-2 selective agonists and antagonists |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076699A2 Method of inhibiting osteoclast activity |
| 02/21/2001 | EP1076698A2 Transgenic plant-derived human blood coagulation factors |
| 02/21/2001 | EP1076697A2 Semaphorin polypeptides |
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076695A1 METHODS AND COMPOSITIONS FOR SCREENING FOR MODULATORS OF IgE SYNTHESIS, SECRETION AND SWITCH REARRANGEMENT |
| 02/21/2001 | EP1076694A1 Methods and substances for preventing and treating autoimmune disease |
| 02/21/2001 | EP1076690A2 Methods for modulating differentiation |
| 02/21/2001 | EP1076666A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 02/21/2001 | EP1076664A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 02/21/2001 | EP0871470A4 Haemopoietic growth factor antagonists and uses therefor |
| 02/21/2001 | EP0835238B1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | EP0652968B1 Defective adenoviruses |
| 02/21/2001 | EP0580635B2 Modified plant viruses as vectors |
| 02/21/2001 | EP0527852B2 Method and compositions for treating injury |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1284999A Maize H3C4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 02/21/2001 | CN1284996A Tumor antigen protein, gene thereof, and utilization thereof |
| 02/21/2001 | CN1284995A Tissue cement proteins from rhipicephalus appendiculatus |
| 02/21/2001 | CN1284966A Novel G protein-coupled receptor |
| 02/21/2001 | CN1284965A Novel surface protein of i (neisseria meningitidis) |
| 02/21/2001 | CN1284963A A method for the removal of causative agent(s) of transmissible spongiform |
| 02/21/2001 | CN1284962A Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/21/2001 | CN1284885A Vaccine |
| 02/21/2001 | CN1284884A 疫苗 Vaccine |
| 02/21/2001 | CN1284882A Beta-lipotropin and uses thereof |
| 02/21/2001 | CN1284881A Heparin cofactor II preparations and process for producing the same |
| 02/21/2001 | CN1284561A Proline transport protein gene in rice |
| 02/21/2001 | CN1062274C Alpha derivative of human tumor necrosin and its preparation |
| 02/20/2001 | US6191343 Molecular methods of hybrid seed production |
| 02/20/2001 | US6191342 Transgenic mice expressing the HIK-ras 4B chimeric gene |
| 02/20/2001 | US6191270 Nucleotide sequences coding plasmodium protein; for prevention and immunization against plasmodium infection |
| 02/20/2001 | US6191269 Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
| 02/20/2001 | US6191268 Nucleotide sequence coding human maintenance protein; for the detection and treatment of tumors; for the detection of oncogenes |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191260 Brain-associated inhibitor of tissue-type plasminogen activator |
| 02/20/2001 | US6191259 Peptide capable of activation of lymphocytes; for the diagnosis and prevention of bacterial infection; for the prevention of vision defects |
| 02/20/2001 | US6191258 Polypeptide which associates with symetric nucleotide sequences; for the artificial regulation of gene expression in plants |
| 02/20/2001 | US6191257 Natural or recombinant DNA binding proteins as carriers for gene transfer or gene therapy |
| 02/20/2001 | US6191256 Recombinant factor VIII binding peptides |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191114 Immunological activity for a peptide of the limulus anti-LPS factor |
| 02/20/2001 | US6191113 Peptide for inhibiting growth of smooth muscle cells |
| 02/20/2001 | US6191112 Human therapeutic uses of BPI protein products |
| 02/20/2001 | US6191110 Promoting wound healing in mammals with peptides |
| 02/20/2001 | US6191108 RH blood group antigen compositions and methods of use |
| 02/20/2001 | US6191107 Complexes with biodregadable polymers |
| 02/20/2001 | US6191106 Muteins of epidermal growth factor exhibiting enhanced binding at low pH |
| 02/20/2001 | US6191105 Insulin free compositions with insulin-methyl(ethylene glycol)-o-hexanoic acid conjugate and composition with water in oil microemulsion |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6191102 Glucagon like peptide |
| 02/20/2001 | US6190914 Methods for modulating metabolic pathways of micro-organisms and micro-organisms obtainable by said methods |
| 02/20/2001 | US6190912 Nucleotide sequences coding modulator of cell killing; for the treatment of cell proliferation defects |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190902 Deformylation of f-met peptides in bacterial expression system |
| 02/20/2001 | US6190901 Chicken interleukin-15 and uses thereof |
| 02/20/2001 | US6190887 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 02/20/2001 | US6190886 Trimerizing polypeptides, their manufacture and use |
| 02/20/2001 | US6190884 Transforming host cell with polynucleotide which encodes the growth factor of defined amino acid sequence, and culturing for gene expression |
| 02/20/2001 | US6190882 Amino acid sequences of rigui1 protein; recombinant production; detection of gene expression in samples |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190867 Methods and means relating to quiescent cells and uses thereof |
| 02/20/2001 | US6190864 HCV genomic sequences for diagnostics and therapeutics |
| 02/20/2001 | US6190862 Identification, purification and detection of WSBV baculovirus associated with white spot syndrome |
| 02/20/2001 | US6190861 Molecular sequences of swine retroviruses method of using |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190669 Attenuated mutants of salmonella which constitutively express the Vi antigen |
| 02/20/2001 | US6190668 Providing cell mass of moraxella catarrhalis strain grown under iron-starved conditions to stimulate transferrin receptor protein expression; selectively extracting aqueous soluble proteins; separation; solubilizing; purification mass |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190666 Can be used to transform animal cells for use in efficient production of desired products, such as proteins and vaccines |
| 02/20/2001 | US6190662 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 02/20/2001 | US6190661 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
| 02/20/2001 | US6190659 For thrombolytic therapy in treatment of coronary and pulmonary thrombosis; in vaccines to abrogate streptococcal infection |
| 02/20/2001 | CA2302629C Estrogen receptor |
| 02/20/2001 | CA2206399C Method for secreting thrombopoietin polypeptides |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/20/2001 | CA2197233C Methods of identifying compounds useful for treating autoimmune diseases |
| 02/20/2001 | CA2195005C Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 02/20/2001 | CA2179771C Non-toxic mucosal adjuvant |
| 02/20/2001 | CA2139846C Modular promoter construct |
| 02/20/2001 | CA2125037C Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
| 02/20/2001 | CA2119651C Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 02/20/2001 | CA2084386C Hiv antigen |
| 02/20/2001 | CA2072658C Use of honey as vaccine |
| 02/20/2001 | CA2060208C Wound healing |
| 02/20/2001 | CA2043536C Tumor cell growth inhibitor |
| 02/20/2001 | CA2033730C Heparin-binding growth factor |
| 02/20/2001 | CA1341185C Intercellular adhesion molecules and their binding ligands |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |